Skye Bioscience, Inc. SKYE

1.67 (0.03) (1.76%) as of 25 Sep
Market cap
$7.5M
P/E
0.0×

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Jun '26 Mar '26 Dec '25 Sep '25 Older periods
Cash and Short Term Investments
10.06 17.11 25.74 35.31

+8 more quarters

Other current assets
0.48 0.23 0.85 0.90
Total current assets
10.96 18.57 27.09 39.92
Property, Plant, Equpment (Net)
0.03 0.76 0.90 1.03
Long-term assets (Other)
0.01 0.04 0.05 0.05
Total non-current assets
0.07 0.85 1.22 1.40
Total Assets
11.03 19.42 28.31 41.32
Accounts Payable
4.28 3.94 2.03 2.83
Accrued Expenses
0.69 0.23 1.27 0.92
Other current liabilities
6.53 6.17 4.71 4.42
Total current liabilities
11.53 10.40 8.21 8.37
Total non-current liabilities
— — 0.08 0.12
Total liabilities
11.53 10.40 8.29 8.49
Additional Paid In Capital
209.64 208.36 206.87 205.24
Common Stock (Net)
0.04 0.04 0.03 0.03
Retained Earnings
(210.17) (199.38) (186.87) (172.43)
Common Equity (Total)
(0.50) 9.01 20.02 32.84
Shareholders Equity (Total)
(0.50) 9.01 20.02 32.84
Shareholders Equity and Liabilities (Total)
11.03 19.42 28.31 41.32
Shares (Common)
4.39 4.39 4.17 3.87
Shareholders Equity (Tangible)
(0.50) 9.01 20.02 32.84
Net Debt
(10.06) (17.11) (25.74) (35.31)

Fold the line items

In millions of $ except per-share values · columns are period end dates